Nanjing Well Pharmaceutical Group Co.,Ltd. (603351.SS)
CNY 21.77
(-5.68%)
CNY 21.77
(-5.68%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 1.15 Billion | 1.11 Billion | 1.04 Billion | 736.06 Million | 880.75 Million | 801.45 Million |
| Cost of Revenue | 842.97 Million | 807.96 Million | 747.92 Million | 484.23 Million | 577.52 Million | 552.14 Million |
| Gross Profit | 312.86 Million | 303.04 Million | 294.38 Million | 251.82 Million | 303.22 Million | 249.3 Million |
| Operating Expenses | 195.02 Million | 182.02 Million | 165.46 Million | 137.4 Million | 146.18 Million | 115.39 Million |
| Selling, General and Administrative Expenses | 121.78 Million | 65.88 Million | 49.89 Million | 26 Million | 55.14 Million | 45.04 Million |
| Research and Development Expenses | 55.64 Million | 53.86 Million | 41.45 Million | 36.58 Million | 32.91 Million | 24.69 Million |
| Other Expenses | 13.65 Million | 62.27 Million | 74.11 Million | 74.8 Million | 58.13 Million | 3.4 Million |
| Cost and Expenses | 1.03 Billion | 989.98 Million | 913.38 Million | 621.63 Million | 723.71 Million | 667.54 Million |
| Operating Income | 121.77 Million | 113.22 Million | 119.75 Million | 118.91 Million | 157.16 Million | 127.64 Million |
| Interest Expense | 15.51 Million | 11.17 Million | 7.04 Million | 5 Million | 4.91 Million | 5.32 Million |
| Income Tax Expense | 12.32 Million | 18.41 Million | 18.58 Million | 17.83 Million | 26.01 Million | 19.23 Million |
| Earnings before Tax | 121.44 Million | 112.85 Million | 118.73 Million | 118.28 Million | 154.11 Million | 131.04 Million |
| Net Income | 112.19 Million | 95.02 Million | 101.37 Million | 100.44 Million | 128.1 Million | 111.81 Million |
| Earnings Per Share Basic | 0.83 | 0.72 | 0.78 | 0.77 | 0.98 | 1.14 |
| Earnings Per Share Diluted | 0.83 | 0.72 | 0.78 | 0.77 | 0.98 | 1.14 |
| Weighted Average Shares Outstanding | 135.17 Million | 132.59 Million | 130.66 Million | 130.66 Million | 130.66 Million | 97.83 Million |
| Weighted Average Shares Outstanding (Diluted) | 135.17 Million | 132.59 Million | 130.66 Million | 130.66 Million | 130.66 Million | 97.83 Million |
| Gross Margin | 0.27 | 0.27 | 0.28 | 0.34 | 0.34 | 0.31 |
| EBIT Margin | 0.18 | 0.17 | 0.16 | 0.21 | 0.22 | 0.21 |
| Profit Margin | 0.10 | 0.09 | 0.10 | 0.14 | 0.15 | 0.14 |
| EBITDA | 209.72 Million | 198.28 Million | 168.58 Million | 158.69 Million | 194.14 Million | 165.04 Million |
| Earnings Before Tax Margin | 0.11 | 0.10 | 0.11 | 0.16 | 0.18 | 0.16 |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
|---|---|---|---|---|---|---|
| Revenue | 312.2 Million | 356.15 Million | 329.83 Million | 1.15 Billion | 327.15 Million | 305.7 Million |
| Cost of Revenue | 231.76 Million | 271.65 Million | 243.99 Million | 839.03 Million | 236.06 Million | 227.96 Million |
| Gross Profit | 80.44 Million | 84.5 Million | 85.83 Million | 316.8 Million | 91.09 Million | 77.74 Million |
| Operating Expenses | 43.83 Million | 42.43 Million | 42.33 Million | 178.27 Million | 48.45 Million | 46.61 Million |
| Selling, General and Administrative Expenses | 62.19 Million | 25.4 Million | 25.67 Million | - | -25.85 Million | 59.58 Million |
| Research and Development Expenses | 15.85 Million | 13.18 Million | 15.76 Million | - | 15.08 Million | 15.15 Million |
| Other Expenses | -34.22 Million | -3.84 Million | -11.68 Thousand | -335.29 Thousand | -183.96 Thousand | -20.37 Thousand |
| Cost and Expenses | 275.59 Million | 314.09 Million | 286.33 Million | 1.01 Billion | 284.52 Million | 274.58 Million |
| Operating Income | 34.19 Million | 42.06 Million | 40.84 Million | 121.77 Million | 37.82 Million | 27.34 Million |
| Interest Expense | 2.93 Million | 4.43 Million | 3.18 Million | 15.25 Million | 4.38 Million | 3.56 Million |
| Income Tax Expense | 781.32 Thousand | 9.6 Million | 7.31 Million | 12.32 Million | 4.5 Million | 3.31 Million |
| Earnings before Tax | 34.09 Million | 53.8 Million | 40.82 Million | 121.44 Million | 37.64 Million | 27.32 Million |
| Net Income | 34 Million | 44.29 Million | 34.6 Million | 112.19 Million | 33.92 Million | 24.88 Million |
| Earnings Per Share Basic | 0.25 | 0.34 | 0.26 | - | 0.44 | 0.19 |
| Earnings Per Share Diluted | 0.25 | 0.34 | 0.26 | - | 0.44 | 0.19 |
| Weighted Average Shares Outstanding | 135.43 Million | 131.08 Million | 133.09 Million | 135.17 Million | 133.47 Million | 132.55 Million |
| Weighted Average Shares Outstanding (Diluted) | 135.43 Million | 131.08 Million | 133.09 Million | 135.17 Million | 133.47 Million | 132.55 Million |
| Gross Margin | 0.26 | 0.24 | 0.26 | 0.27 | 0.28 | 0.25 |
| EBIT Margin | 0.12 | 0.19 | 0.13 | - | 0.13 | 0.10 |
| Profit Margin | 0.11 | 0.12 | 0.10 | 0.10 | 0.10 | 0.08 |
| EBITDA | 37.03 Million | 67.94 Million | 44.28 Million | - | 42.84 Million | 31.03 Million |
| Earnings Before Tax Margin | 0.11 | 0.12 | 0.12 | 0.11 | 0.12 | 0.09 |
3520
WNEB
4554
RDEXF
SE
0857